FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical composition possessing anti-inflammatory, broncholytic and anti-tuberculosis activity, which represents N-(5-ethyl-1,3,4-thiadiazole-2-yl)-4-nitrobenzamide. Obtained results of pharmacological study showed that claimed compound possesses high anti-inflammatory, broncholytic and anti-tuberculosis activity, which are not worse and in some cases is better than known applied in medicine preparations. Elaborated is solid dosed pharmaceutical composition based on claimed compound, made in form of tablets, or capsules, or in form of powder for preparation of suspension for drinking.
EFFECT: obtaining possibility to apply claimed pharmaceutical compositions based on claimed compound for prevention and treatment of inflammatory, bronchopulmonary (bronchitis, pneumonia, bronchial asthma) diseases, tuberculosis.
4 cl, 10 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION, CONTAINING DERIVATIVES OF GLUTARIMIDES, AND THEIR APPLICATION FOR TREATMENT OF EOSINOPHILIC DISEASES | 2013 |
|
RU2552929C1 |
PHARMACEUTICAL COMPOSITION, CONTAINING N-ACYL DERIVATIVES OF AMINO ACIDS, AND THEIR APPLICATION AS ANTI-ALLERGIC, ANTI-ANAPHYLACTIC AND ANTI-INFLAMMATORY MEDICATIONS | 2008 |
|
RU2406727C2 |
PHARMACEUTICAL COMPOSITION BASED ON GLUCOCORTICOSTEROID BUDESONIDE AND PHOSPHATIDYLCHOLINE FOR DRY INHALATION | 2019 |
|
RU2730488C1 |
N-ACYL DERIVATIVES OF AMINOACIDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION AND APPLICATION AS HYPOLIPIDEMIC PREPARATIONS | 2005 |
|
RU2335495C2 |
TUBERCULOUS AGENT AS SOLUTION FOR INJECTION | 2007 |
|
RU2358742C2 |
5-ETHYL-2-AMINO-1,3,4-THIADIAZOLE DERIVATIVES WITH ANESTHETIC, ANTI-INFLAMMATORY, ANTI-ALLERGIC AND ANALGETIC ACTIVITY | 2016 |
|
RU2651572C2 |
DRUG PREPARATION FOR TREATING TUBERCULOSIS | 2013 |
|
RU2523792C9 |
METHOD OF PRODUCING N-ACYL DERIVATIVES OF AMINO ACIDS (VERSIONS) | 2008 |
|
RU2378284C2 |
2-HYDROXY-3-METHOXYBENZALDEHYDE ISONICOTINOYL HYDRAZONE SHOWING ANTIASTHMATIC, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTIVITY | 1997 |
|
RU2139711C1 |
NEW INHIBITOR OF GLUTAMINYL CYCLASE AND ITS USE FOR TREATMENT OF LUNG AND RESPIRATORY DISEASES | 2017 |
|
RU2662559C1 |
Authors
Dates
2012-04-27—Published
2011-02-03—Filed